Marimed (MRMD) Shares Outstanding (2011 - 2026)
Marimed (MRMD) posted quarterly Shares Outstanding (Entity) of $398.9 million for Q1 2026, up 2.63% year-over-year from $388.7 million in Q1 2025, and up 0.5% quarter-over-quarter from $396.9 million in Q4 2025.
Marimed (MRMD) Shares Outstanding (2011 - 2026) Analysis & Trends
Marimed (MRMD) has reported Shares Outstanding (Entity) for 16 consecutive years, with $398.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 2.63% year-over-year to $398.9 million; the TTM figure through Mar 2026 stood at $398.9 million (up 2.63% YoY), while the FY2025 annual figure was $396.9 million, up 4.05% from the prior year.
- Shares Outstanding (Entity) rose to $398.9 million in Q1 2026 per MRMD's latest filing, from $396.9 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $398.9 million in Q1 2026 and bottomed at $335.6 million in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $371.5 million across 5 years, with a median of $375.9 million in 2023.
- Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) increased 10.79% — and 2024, when it climbed 1.36%.
- Marimed's Shares Outstanding (Entity) stood at $341.5 million in 2022, then increased by 9.85% to $375.1 million in 2023, then increased by 1.69% to $381.5 million in 2024, then increased by 4.05% to $396.9 million in 2025, then advanced by 0.5% to $398.9 million in 2026.
- Business Quant data shows MRMD's Shares Outstanding (Entity) at $398.9 million in Q1 2026, $396.9 million in Q4 2025, and $394.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 832.44 Mn |
| 10 | Marimed | 27.77 Mn | 19.33 Mn | 16.23 Mn | 399.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 399.60 Mn |
| Mar 31, 2026 | 397.45 Mn |
| Dec 31, 2025 | 390.14 Mn |
| Sep 30, 2025 | 392.61 Mn |
| Jun 30, 2025 | 389.90 Mn |
| Mar 31, 2025 | 382.56 Mn |
| Dec 31, 2024 | 379.15 Mn |
| Sep 30, 2024 | 380.60 Mn |
| Jun 30, 2024 | 379.51 Mn |
| Mar 31, 2024 | 375.21 Mn |
| Dec 31, 2023 | 363.40 Mn |
| Sep 30, 2023 | 373.08 Mn |
| Jun 30, 2023 | 361.26 Mn |
| Mar 31, 2023 | 342.79 Mn |
| Dec 31, 2022 | 337.70 Mn |
| Sep 30, 2022 | 339.03 Mn |
| Jun 30, 2022 | 337.50 Mn |
| Mar 31, 2022 | 334.76 Mn |
| Dec 31, 2021 | 326.47 Mn |
| Sep 30, 2021 | 329.45 Mn |